Elliott M. Levy's most recent trade in Editas Medicine Inc was a trade of 37,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Editas Medicine Inc | Elliott M. Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 37,500 | 37,500 | - | - | Stock Option (right to buy) | |
| Omega Therapeutics Inc | Elliott M. Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Editas Medicine Inc | Elliott M. Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Omega Therapeutics Inc | Elliott M. Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 18,118 | 18,118 | - | - | Stock Option (Right to Buy) | |
| Editas Medicine Inc | Elliott M. Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2023 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Omega Therapeutics Inc | Elliott M. Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 18,118 | 18,118 | - | - | Option (Right to Buy) |